These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12092233)

  • 1. [Nebivolol treatment in essential arterial hypertension].
    Ghiuru R; Rezuş C; Ambăruş V; Ionescu S; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):756-9. PubMed ID: 12092233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol in the management of essential hypertension: a review.
    McNeely W; Goa KL
    Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of nebivolol in patients with mild and moderate hypertension].
    Zhigunova LV; Lakhova EL; Iurenev AP
    Ter Arkh; 2003; 75(3):59-61. PubMed ID: 12718224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V
    Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(4):253-60. PubMed ID: 19655820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J; Faulhaber HD
    Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
    Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
    Punzi H; Lewin A; Lukić T; Goodin T; Wei Chen
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):349-57. PubMed ID: 21088095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol/hydrochlorothiazide (HCTZ) combination in patients with essential hypertension: a pooled analysis from five non-interventional studies with a focus on diabetic and elderly patients.
    Malacco E
    Eur Rev Med Pharmacol Sci; 2010 May; 14(5):427-34. PubMed ID: 20556921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol: a new antihypertensive agent.
    Gray CL; Ndefo UA
    Am J Health Syst Pharm; 2008 Jun; 65(12):1125-33. PubMed ID: 18541682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
    Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.